CABLIVI (caplacizumab-yhdp) for injection
CABLIVI is a prescription medicine used to treat aTTP. FDA approved caplacizumab-yhdp (brand name CABLIVI) is not (yet) registered or available in India but on request Indian patient can buy CABLIVI at the lowest price.

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
CABLIVI (caplacizumab-yhdp) for injection
Caplacizumab is a bivalent single-domain antibody (VHH) designed for the treatment of thrombotic thrombocytopenic purpura (TTP) and thrombosis.
CABLIVI is a von Willebrand factor (vWF)-directed antibody fragment indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.
Caplacizumab (INN; trade name Cablivi) is a bivalent single-domain antibody (VHH) designed for the treatment of thrombotic thrombocytopenic purpura (TTP) and thrombosis. It is an anti-von Willebrand factor humanized immunoglobulin. In February 2019, caplacizumab-yhdp (Cablivi, Ablynx NV) was approved in the United States for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP). The drug is used in combination with plasma exchange and immunosuppressive therapy. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.
CABLIVI (caplacizumab-yhdp) for injection, for intravenous or subcutaneous use Initial U.S. Approval: 2019
—————-
Current Indication: Treat of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.
—————-
Marketed By: Ablynx US
—————-
Approval Date: : 2019
—————-
Active ingredient: caplacizumab-yhdp
—————-
For injection: 11 mg as a lyophilized powder in a single-dose vial.
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ CABLIVI (caplacizumab-yhdp) for injection ”. Confirmation of the order for CABLIVI (caplacizumab-yhdp) for injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Request to call @ +91-9289711087 / 9289711088 or WhatsApp @ +91-9289711087 / 9289711088 or mail @ – info@alleviareindia.com + for CABLIVI availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Get Access to Treatment – CABLIVI
We have delivered medicines to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
CABLIVI Sourcing & Delivery
Alleviare India specializes in sourcing and supplying CABLIVI, a cancer treatment medicine, from around the world. They offer worldwide access to the best available treatment options. Alleviare India can dispense any valid prescription quickly and helps connect patients with potential distributors, wholesalers, suppliers, and dealers of CABLIVI in India.
How much does CABLIVI cost in the India?
Kindly reach out to us for CABLIVI (caplacizumab-yhdp) for injection price and availability confirmation. The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply
What documents are required to import CABLIVI to India?
To import caplacizumab-yhdp – CABLIVI, patients or government hospitals can place an order on behalf of the patients. The following documentation is required for the import process:
- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ ID proof issued by the Government of India.
The order will be confirmed only after the receipt of the following:
- Valid prescription from the doctor.
- Import permit, if applicable.
Please ensure that all the necessary documentation is provided to confirm the order.
Is CABLIVI available in India?
CABLIVI – caplacizumab-yhdp is a prescription medication, which means it legally requires a medical prescription to be dispensed. Alleviare India assists in importing cancer medicines through the named patient supply (NPS) program. They provide information on the availability and prices of medications in various cities in India, such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune. Alleviare ensures 100% transparency and helps find genuine and reliable sources from Canada, Europe, USA, and Australia. They can facilitate the supply of CABLIVI (prescription medicines) to locations worldwide, including India, while ensuring compliance with legal requirements.
Request to call @ +91-9289711087 / 9289711088 or WhatsApp @ +91-9289711087 / 9289711088 or mail @ – info@alleviareindia.com + for CABLIVI availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Is caplacizumab-yhdp available in India?
Yes, FDA approved caplacizumab-yhdp (brand name CABLIVI) is not (yet) registered or available in India but on request Indian patient can buy CABLIVI at the lowest price. Alleviare will help patient / doctor to get in India.
How overseas patient can get access?
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand CABLIVI (caplacizumab-yhdp) for injection . The import process requires a valid prescription and an Import License in the Patient’s Name.